Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
-38K
-
Total reported value, excl. options
-
$481M
-
Value change
-
-$751K
-
Put/Call ratio
-
1.06
-
Number of buys
-
55
-
Number of sells
-
-68
-
Price
-
$4.79
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2021
168 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q4 2021.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
of 316M outstanding shares and own 31.88% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG GP A, LLC (16.2M shares), VANGUARD GROUP INC (11.6M shares), BlackRock Inc. (6.99M shares), Eversept Partners, LP (6.44M shares), Point72 Asset Management, L.P. (3.31M shares), Neuberger Berman Group LLC (3.27M shares), STATE STREET CORP (2.49M shares), Nuveen Asset Management, LLC (1.81M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.76M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.